跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEEFLOX - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
LEEFLOX
Approved
STANDARD
LEEFLOX
Centaur Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
70a4d73888b9f08d
Company
Centaur Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
70a4d73888b9f08d
Drug Approval Philippines Name
LEEFLOX
Product Name
LEEFLOX
Registration Number
DRP-2374
Brand Name
LEEFLOX
Generic Name
LEVOFLOXACIN (AS HEMIHYDRATE)
Dosage Form
Ophthalmic Solution
Dosage Strength
5mg/mL (0.5% w/v)
Manufacturer
Centaur Pharmaceuticals Pvt. Ltd.
Importer
Stangen Pharmaceuticals Philippines, Inc.
Distributor
Avantmed International Pharma, Inc.
Company Detail Path
/organization/centaur-pharmaceuticals-pvt-ltd
Issuance Date
18 August 2023
Expiry Date
05 August 2028
Pharmacologic Category
ANTIBACTERIAL (QUINOLONE)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
70a4d73888b9f08d
Type
Standard
Back to Philippines FDA Approvals